Pharmaceutical News and Articles

More Drugmakers Join TrumpRx

WEDNESDAY, April 8, 2026 Drug companies Abbvie and Genentech will start selling medications at lower prices through the White House s TrumpRx website. They are

Shape-Sensing Robotic-Assisted Bronchoscopy Safe for Identifying Lung Cancer

Shape-sensing robotic-assisted bronchoscopy (ssRAB) demonstrates a high diagnostic performance for pulmonary lesions, with high sensitivity for malignancy, acco

SaFETy Score in ED Predicts 12-Month Risk for Firearm Violence

For young adults presenting to the emergency department (ED), the Serious fighting, Friend weapon carrying, community Environment, and firearm Threats (SaFETy)

AAD: Subcutaneous Amlitelimab Aids Atopic Dermatitis Outcomes Through Week 24

Amlitelimab, a fully human non-T cell depleting monoclonal antibody that selectively targets OX40-ligand (OX40L), is safe and effective, with potentially progre

Use of Evaluation, Management Add-On Code G2211 Remains Below Projected Adoption Levels

Use of the new Centers for Medicare Medicaid Services evaluation and management (E M) add-on code, G2211, which was established to better account for previously

Never-Married Adults Have Increased Cancer Incidence

Adults who have never been married have an increased risk for developing cancer, according to a study published online April 8 in Cancer Research Communications

Nuvalent Announces Submission of New Drug Application to FDA for Neladalkib in TKI Pre-treated Advanced ALK-Positive NSCLC

American College of Cardiology, March 28-30

For adults aged 50 years and older with a diagnosis of atherosclerotic cardiovascular disease, herpes zoster vaccination is associated with a lower risk for maj

FDA Approves First Generic Farxiga (dapagliflozin) Tablets

The U.S. Food and Drug Administration approved the first generics of Farxiga (dapagliflozin) tablets to reduce the risk of hospitalization for heart failure in

Walking Is the Most Common Leisure-Time Physical Activity for U.S. Adults

Walking is the most common leisure-time physical activity (LTPA) among U.S. adults, but many who engage in walking still don t meet physical activity guidelines